rofecoxib has been researched along with Heart Diseases in 5 studies
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verrico, MM | 1 |
| Weber, RJ | 1 |
| McKaveney, TP | 1 |
| Ansani, NT | 1 |
| Towers, AL | 1 |
| White, WB | 1 |
| Hefer, E | 1 |
| Wadman, M | 1 |
| Steffel, J | 1 |
| Akhmedov, A | 1 |
| Fähndrich, C | 1 |
| Ruschitzka, F | 1 |
| Lüscher, TF | 1 |
| Tanner, FC | 1 |
5 other studies available for rofecoxib and Heart Diseases
| Article | Year |
|---|---|
Adverse Drug Events Involving COX-2 Inhibitors.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Inflammatory Agents, N | 2003 |
Hypertension associated with therapies to treat arthritis and pain.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agent | 2004 |
["Wise be aware of your sayings"--about gaps between epidemiological data base, experimental results and decision making in health administration].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Databases, Factual; Epidemiology; Estrogen Replacement Ther | 2005 |
How does a painkiller harm the heart?
Topics: Analgesics; Animals; Drug Industry; Epoprostenol; Heart Diseases; Humans; Lactones; Mice; Randomized | 2006 |
Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Celecoxib; Cell Line; Endothelium, Vascula | 2006 |